Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,024 | 14 | 58.7% |
| Travel and Lodging | $721.02 | 3 | 41.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $939.04 | 8 | $0 (2020) |
| Nevro Corp. | $265.69 | 2 | $0 (2019) |
| Abbott Laboratories | $178.07 | 1 | $0 (2022) |
| Medtronic, Inc. | $135.39 | 1 | $0 (2021) |
| Avanos Medical | $112.64 | 3 | $0 (2020) |
| GRT US Holding, Inc. | $100.80 | 1 | $0 (2022) |
| SPR Therapeutics, Inc | $13.12 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $278.87 | 2 | Abbott Laboratories ($178.07) |
| 2021 | $135.39 | 1 | Medtronic, Inc. ($135.39) |
| 2020 | $186.66 | 4 | Medtronic USA, Inc. ($92.92) |
| 2019 | $1,144 | 10 | Medtronic USA, Inc. ($846.12) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $178.07 | General |
| Category: Neuromodulation | ||||||
| 06/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Pain Management | ||||||
| 10/06/2021 | Medtronic, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $135.39 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/30/2020 | Medtronic USA, Inc. | MYSTIM (Device) | Food and Beverage | In-kind items and services | $74.82 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/26/2020 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: Pain management | ||||||
| 08/12/2020 | Medtronic USA, Inc. | MYSTIM (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/16/2020 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $80.62 | General |
| Category: SURGICAL PAIN | ||||||
| 10/16/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $144.86 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/02/2019 | Avanos Medical | PNB AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: SURGICAL PAIN | ||||||
| 10/02/2019 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: SURGICAL PAIN | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Travel and Lodging | In-kind items and services | $390.40 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Travel and Lodging | In-kind items and services | $297.72 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $60.96 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $57.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Travel and Lodging | In-kind items and services | $32.90 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/14/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 521 | 727 | $248,435 | $81,231 |
| 2022 | 16 | 566 | 806 | $241,489 | $83,591 |
| 2021 | 11 | 448 | 567 | $194,171 | $68,513 |
| 2020 | 2 | 55 | 64 | $21,938 | $8,049 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 252 | $73,962 | $27,107 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $59,706 | $20,072 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 60 | $23,939 | $8,766 | 36.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 45 | 60 | $16,320 | $5,239 | 32.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 34 | 45 | $15,107 | $5,224 | 34.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 14 | 19 | $15,453 | $4,058 | 26.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 33 | 44 | $19,456 | $2,918 | 15.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 12 | 17 | $6,056 | $2,097 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $5,705 | $2,034 | 35.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 14 | 27 | $5,751 | $1,654 | 28.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 16 | $3,031 | $1,244 | 41.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 12 | 12 | $3,950 | $817.61 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 217 | $57,575 | $23,433 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 140 | 140 | $56,140 | $20,271 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 65 | $22,945 | $10,290 | 44.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 21 | 27 | $23,744 | $5,657 | 23.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 34 | 48 | $15,710 | $4,237 | 27.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 21 | 29 | $8,120 | $2,908 | 35.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 23 | 23 | $7,491 | $2,742 | 36.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 20 | 40 | $9,486 | $2,499 | 26.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 20 | 27 | $10,444 | $2,451 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $5,440 | $2,085 | 38.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 15 | 18 | $4,730 | $1,925 | 40.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 19 | $3,433 | $1,491 | 43.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 21 | 21 | $9,120 | $1,402 | 15.4% |
About Dr. Thomas Cestare, MD
Dr. Thomas Cestare, MD is a Interventional Pain Medicine healthcare provider based in Brandywine, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1013303320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Cestare, MD has received a total of $1,745 in payments from pharmaceutical and medical device companies, with $278.87 received in 2022. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,024).
As a Medicare-enrolled provider, Cestare has provided services to 1,590 Medicare beneficiaries, totaling 2,164 services with total Medicare billing of $241,384. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Location Brandywine, MD
- Active Since 04/13/2015
- Last Updated 05/14/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013303320
Products in Payments
- INTELLIS (Device) $981.51
- Senza Spinal Cord Stimulation System (Device) $265.69
- PROCLAIM (Device) $178.07
- Qutenza (Drug) $100.80
- ON-Q* PUMP AND ACCESSORIES (Device) $96.16
- MYSTIM (Device) $92.92
- PNB AND ACCESSORIES (Device) $16.48
- SPRINT PNS System (Device) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.